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Abstract
Background: Symptoms of heartburn has an impact on health-related quality of life (HRQL).
When a questionnaire is translated into a new language, a linguistic validation is necessary but not
sufficient unless the psychometric characteristics have been verified. The aim is to document the
psychometric characteristics of the German translation of the Gastrointestinal Symptom Rating
Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire.
Methods: 142 patients with symptoms of heartburn (Age: M = 47.5, ± 14.6; Males = 44.4%)
completed the German translation of GSRS, the QOLRAD, the Short-Form-36 (SF-36) and the
Hospital Anxiety and Depression (HAD) scale.
Results: The internal consistency reliability of GSRS ranged from 0.53–0.91 and of QOLRAD from
0.90–0.94, respectively. The test-retest reliability of GSRS ranged from 0.49–0.73 and of QOLRAD
from 0.70–0.84. The relevant domains of the GSRS and QOLRAD domain scores significantly
correlated. GSRS domains of Abdominal Pain and Constipation correlated (negatively) with most
of the domains of the SF-36. The relevant QOLRAD domains significantly correlated with all SF-36
domains.
Conclusions: The psychometric characteristics of the German translation of GSRS and QOLRAD
were found to be good, with satisfactory reliability and validity. The reliability of the GSRS
Abdominal Pain domain was moderate.
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Background
Heartburn is the primary symptom of gastro-esophageal
reflux disease (GERD). The diagnosis relies solely on
patients' subjective symptom evaluation unless an endos-
copy is performed [1]. Heartburn affects several aspects of
patients' lives [2,3], such as their ability to have a good
night sleep and to eat and drink whatever they want [4].
Hence, the assessment of how upper gastrointestinal
symptoms impact patients' health-related quality of life
provides important information about the patient's
health status and how patients perceive the treatment
regime [5]. This information is of interest to clinicians,
enabling them to better understand how to tailor treat-
ment to the individual patient's needs. However, in order
to be a viable measure of treatment outcome in clinical tri-
als, Patient-Reported Outcomes (PRO) instruments must
be extensively documented to both meet scientific stand-
ards [6] and to satisfy regulatory criteria, particularly from
the perspective of claims for labeling and promotion [7].
The regulatory criterion is twofold: linguistic, cross-cul-
tural adaptation and psychometric documentation. The
translation and the cross-cultural adaptation of the Ger-
man translation of the QOLRAD were done according to
the latest guidelines [8]. Its psychometric properties
remain to be documented. Thus, the aim of this study was
to document the reliability and validity of the German
translation of the GSRS and QOLRAD in patients with
GERD.
Methods
Patients
Consecutive patients with current or previously verified
(there was no definite time frame given) predominant
symptoms of heartburn were screened in both general
practices and gastroenterology clinics. Heartburn was
defined as a 'burning feeling rising from the stomach or
lower part of the chest up towards the neck'. Patients were
excluded if they had: concurrent diagnosis of Irritable
Bowel Syndrome (IBS) or peptic ulcer disease; other sig-
nificant medical or surgical disease; major psychiatric ill-
ness or dementia. Patients treated for peptic ulcer with
anti-secretory or anti-Helicobacter pylori therapy and
referred for follow-up endoscopy or those using of acetyl
salicylic acid (ASA) or other nonsteroidal anti-inflamma-
tory drugs (NSAIDs) daily were also excluded. Patients
had to be able to complete the PRO instruments them-
selves, i.e. no proxy assessment or interpreter was allowed.
The study was conducted between December 2000 and
November 2001 in five centers. Written informed consent
was obtained from all patients prior to inclusion in the
trial. The study protocol and consent form were approved
by independent local ethics committee in accordance with
the revised Declaration of Helsinki. The patient was free to
discontinue participation in the study at any time.
Demographic and clinical variables
Clinicians reported: patient demographics (age, sex, race,
family and employment status); medical history; history
of gastrointestinal disease; and frequency and severity of
heartburn symptoms. Investigators also assessed the
patients' symptoms using a four-graded scale: 0 = none:
no symptoms; 1 = mild: awareness of sign or symptom,
but easily tolerated; 2 = moderate: discomfort sufficient to
cause interference with normal activities; 3 = severe: inca-
pacitating with inability to perform normal activities. All
data were reported in a paper case report form.
Patient-Reported Outcomes (PRO) instruments
Generic instruments are comprehensive, designed to be
applicable across diseases, treatments and populations.
Both general population norm values and values of pop-
ulations with a number of chronic diseases are available.
Disease-specific instruments, on the other hand, capture
details about the disease activity and symptom patterns
and are likely to be more responsive to change than
generic instruments [9,10]. Taking into consideration the
complementary nature of these different kinds of instru-
ments, disease-specific and generic instruments are in
practice often used in tandem.
Patients completed four PRO instruments: Gastrointesti-
nal Symptom Rating Scale (GSRS) [11]; the heartburn ver-
sion of Quality of Life in Reflux and Dyspepsia
(QOLRAD) [12] questionnaire; the Short-Form Health 36
(SF-36) [13]; and the Hospital Anxiety and Depression
scale (HAD) [14]. All PRO instruments have been tested
in terms of validity and reliability (see below).
Gastrointestinal Symptom Rating Scale (GSRS)
The Gastrointestinal Symptom Rating Scale is a disease-
specific instrument that includes 15 items combined into
five-symptom clusters addressing different gastrointesti-
nal symptoms. The five-symptom clusters depict reflux,
abdominal pain, indigestion, diarrhea and constipation.
The GSRS has a seven-graded Likert type scale where 1 rep-
resents absence of bothersome symptoms and 7 very
bothersome symptoms. The GSRS is well documented to
be reliable and valid [15] and norm values for a general
population are available [16].
Quality of Life in Reflux and Dyspepsia (QOLRAD)
The heartburn version of the QOLRAD is a disease-specific
instrument, including twenty-five items combined into
five dimensions: Emotional distress, Sleep disturbance,
Vitality, Food/drink problems and Physical/social func-
tioning. The questions are rated on a seven-graded Likert-
type scale; the lower the value the more severe the impact
on the daily functioning. The QOLRAD has been exten-
sively documented in international studies in patients
with heartburn with regard to reliability, validity [12] andHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/62
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responsiveness [4], assessing the impact of GERD on
patients' HRQL. Previous studies have also revealed that a
change of approximately 0.5 represents a clinically rele-
vant change in the QOLRAD [17]. Its factor structure was
also replicated in several translations [18].
Short-Form Health 36 (SF-36)
The SF-36 is an extensively used generic questionnaire
containing 36 items clustered in eight dimensions. Item
scores for each dimension are coded, summed and trans-
formed to a scale from 0 (worst possible health state
measured by the questionnaire) to 100 (best possible
health state). The higher value indicates a better evalua-
tion of health. The SF-36 is well documented in terms of
reliability and validity in all available language versions
[19,20]. This study used the acute version of the SF-36, i.e.
a one week recall period.
Hospital Anxiety and Depression scale (HAD)
The HAD consists of 14 items divided into two sub-scales
for anxiety (7 items) and depression (7 items), in which
the patient rates each item on a four-point scale. The
higher scores indicate the presence of problems. A cut off
of ≥ 11 implies definite cases, a cut off of 8–10 probable
cases and ≤ 7 no cases. The validity and reliability of the
HAD have been reported in several studies [21,22].
All the above instruments have been translated and lin-
guistically validated according to international guidelines
[8]. The linguistic validation of a questionnaire is not a lit-
eral translation of the original questionnaire, but the pro-
duction of a translation, which is conceptually equivalent
to the original and culturally acceptable in the country in
which the translation will be used. This translation proc-
ess includes forward and backward translations by inde-
pendent translators.
Administration of PRO instruments
All questionnaires were completed in an electronic data
capture device (Apple Newton Pad). The method of using
Electronic Data Capture (EDC) for HRQL studies has pre-
viously been shown to improve the quality of the data and
to be well received by patients [23]. All study personal
were trained to use the EDC and to instruct the patients in
a standardized way for minimizing bias and enhancing
compliance.
Psychometric evaluation of the instruments
Reliability
Internal consistency refers to the extent to which the items
are interrelated. Cronbach's coefficient is one method of
assessing internal consistency and is the method most
widely used for this purpose. Cronbach's alpha was calcu-
lated [24] in each dimension of the instruments to assess
the internal consistency reliability. A high alpha coeffi-
cient (≥ 0.70) suggests that the items within a dimension
measure the same construct and supports the construct
validity.
Test-retest reliability refers to the stability of a score derived
from serial administrations of a measure by the same
rater. Repeated measurements are made in the same indi-
viduals, presumably with a time interval long enough to
ensure independence. Here, patients in the stable phase
(between visits one and two) and in whom the treatment
– not study mandated – remained unchanged were
assessed. A reliability coefficient above 0.70 [10] is con-
sidered to be acceptable.
Construct validity
Construct validity is concerned with whether the indicator
actually measures the underlying attribute. The construct
validity of the GSRS and QOLRAD was examined by con-
vergent, discriminant and known-groups validity.
Convergent validity consists of showing that a postulated
dimension of the instrument correlates appreciably with
all other dimensions that theory suggests should be
related to it. Here, it was was examined by: a) correlating
the QOLRAD and the GSRS; b) correlating the QOLRAD
and the GSRS with the dimensions of SF-36; and c) corre-
lating the QOLRAD and GSRS with the HAD and the cli-
nician-assessed patient heartburn symptoms. Using
Pearson's product moment correlation, similar dimen-
sions in these instruments were expected to have high cor-
relations with each other. A strong correlation was
considered to be over 0.60, a moderate between 0.30 and
0.60 and a low (very low) correlation below 0.30 [25].
Low correlation was expected between those dimensions
that are theoretically unrelated constructs, thereby testing
the discriminant validity of the instruments. Correlating the
QOLRAD and the GSRS with severity and frequency of
heartburn symptoms also tested the discriminant validity
of the instruments. Finally, known-groups validity [26] was
also tested since a PRO instrument should be able to dif-
ferentiate between groups of patients whose health status
differs according to the characteristics of patients' disease,
in this case heartburn severity and frequency [27]. Physi-
cian-assessed overall severity of symptoms and its relation
to the QOLRAD dimensions were also evaluated.
In addition, the SF-36 summary scores were calculated for
the physical component summary scale (PCS) and the
mental component summary scale (MCS) based on Ger-
man data (algorithm) [20] from the IQOLA project [28].
Finally, the HAD was used to evaluate the extent to which
anxiety or depression correlates with the QOLRAD and
the GSRS scores.Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/62
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Statistical methods
Statistical analyses were performed utilizing the Statistical
Analysis System (SAS, version 8.02) [29]. Test results are
reported as significant for P < 0.0003, adjusted for multi-
plicity (Bonferroni's correction [30], 0.05/165). In the
case of missing data in the PRO instruments, the mean of
the completed items in one dimension was imputed to
substitute the missing item provided that more than 50%
of the items in one dimension were completed [31].
Results
Study population
A total of 142 patients (79 females) were included in the
study. The diagnosis was verified at the discretion of the
investigator when the patient fulfilled a history of epi-
sodes of heartburn for six months or longer with episodes
of heartburn for one day or more during the last seven
days prior to inclusion.
Patients' ages ranged from 19 to 79 with a mean of 47.5
years ± 14.6 (Table 1). For patients scheduled for the sec-
ond visit (consecutive patients) there was no change in
the treatment between visits 1 and 2 and the patients were
in a stable phase. All participants were Caucasian, and 66
% were married. 62 % of patients was employed full-time.
Further demographics and clinical characteristics of the
patient population are shown in Table 1.
Patients were recruited with diverse severity of symptoms.
The majority (70%) had moderate symptoms and 15 per-
cent had either severe or mild heartburn symptoms. The
frequency of symptoms was evenly distributed among
those experiencing symptoms one to four days per week.
Forty-six percent of the patients had symptoms more than
five days a week.
The Gastrointestinal Symptom Rating Scale and the 
Quality of Life in Reflux and Dyspepsia questionnaire
Patients were bothered most by symptoms of 'Reflux'
(Mean = 3.9), 'Indigestion' (Mean = 3.3) and 'Abdominal
pain' (Mean = 3.0). The consequences of GI symptoms
were reflected in the following dimensions of the QOL-
RAD: 'Food and Drink Problems' (Mean = 4.4); 'Vitality'
(Mean = 4.6); 'Emotional Distress' (Mean = 5.0); and
'Sleep Disturbance' (Mean = 5.1), in that order. Hence,
patients reported that, because of their symptoms, they
could not eat and drink whatever they liked; their vitality
was impaired; they were emotionally distressed; and they
could not have a good night sleep.
Internal consistency reliability and test-retest reliability
Cronbach's alpha ranged from 0.53 (Abdominal Pain) to
0.91 (Diarrhea) in GSRS. In QOLRAD, the
intercorrelations ranged from 0.90 (Vitality) to 0.94
(Emotional Distress) (Table 2), respectively.
Table 1: Patient demographics and clinical data (N = 142).
Variables
Age: Mean (SD), years 47.5 (14.6)
%
Sex: Female 55.6
Race: Caucasian 100.0
Marital status: Married 66.2
Employment status: Full-time employed 62.0
Part-time employed 7.7
Unemployed 6.3
Homemaker, Student, Early retirement, Retired 24.0
Duration of current episode: <1 month 52.1
1–6 months 19.7
>6 months 28.2
Duration of disease: <1 year 15.5
1–5 years 46.5
>5 years 38.0
Severity of symptoms, last 7 days: Mild 14.8
Moderate 70.4
Severe 14.8
Frequency of symptoms, last 7 days: 1–2 days 31.0
3–4 days 23.3
>5 days 45.7
Previous peptic ulcer and/or ulcerative reflux esophagitis: Yes 7.7
Doctor visit because of emotional problems during the past 5 years: Yes 1.4Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/62
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The test-retest reliability in GSRS ranged from 0.49
(Abdominal Pain) to 0.72 (Constipation), in QOLRAD
from 0.70 (Vitality domain), to 0.84, respectively (Emo-
tional Distress and Food/Drink Problems domain) (Table
2).
Convergent and discriminant validity of Gastrointestinal 
Symptom Rating Scale and Quality of Life in Reflux and 
Dyspepsia
Pearson correlation coefficients were used to assess the
convergent and discriminant validity (Table 3). There was
a negative correlation between the Gastrointestinal Symp-
tom Rating Scale and SF-36 in all domains. GSRS domains
of 'Reflux' and SF-36 'Vitality' and 'Bodily Pain' were sig-
nificantly correlated. The GSRS domains of 'Abdominal
Pain' and 'Constipation' were significantly correlated with
nearly all SF-36 domains in a negative direction. The rele-
vant GSRS domains, 'Reflux', 'Abdominal Pain', and 'Indi-
gestion', correlated significantly with all QOLRAD
domains.
HAD scores yielded positive correlations between GSRS
and anxiety, with significant correlations between anxiety
and 'Abdominal pain' and 'Indigestion'. In addition, phy-
sician-assessed frequency of symptoms and the GSRS
domain of 'Reflux' were significantly correlated.
QOLRAD correlated positively with all domains of the SF-
36. The strongest correlations (>0.50) were found
between QOLRAD 'Emotional Distress', 'Physical/Social
functioning', and 'Vitality' and all SF-36 domains except
for 'General health' and 'Bodily pain'. Furthermore, signif-
icant correlations were found between QOLRAD and anx-
iety and depression in a negative direction. Finally,
QOLRAD and physician-assessed frequency of the symp-
toms significantly correlated in the expected (negative)
direction (Table 3).
Known-groups validity of Gastrointestinal Symptom 
Rating Scale and Quality of Life in Reflux and Dyspepsia
All domains of the GSRS and QOLRAD questionnaires
were able to differentiate between groups of patients
whose health status differed according to the physician-
assessed overall frequency and severity of heartburn,
thereby confirming the known-groups validity of the
instruments (Figures 1 and 2).
Discussion
Clear and consistent associations were found between the
symptoms of heartburn and their impact on patients'
HRQL. In agreement with these results, a recent German
study reported that GERD patients with at least moder-
ately severe reflux symptoms had reduced HRQL [32]. The
relevance of the sample of patients was confirmed when
patients reported that the most bothersome symptoms
they had were heartburn and acid regurgitation (reflux),
indigestion and abdominal pain, in that order. This find-
ing is in accordance with previous descriptions of symp-
tom patterns [2,4,33] in patient with GERD.
One of the most established, validated, reliable and
responsive instruments available in this area is the QOL-
RAD [12], which has been proven to have excellent psy-
chometric characteristics when tested in clinical trials
[34,35].
The primary goal of this study of documenting the psy-
chometric characteristics of the German translation of the
GSRS and QOLRAD was achieved. The reliability of the
most relevant GSRS domain (Reflux) was satisfactory, but
the 'Abdominal Pain' domain was not optimal. The low
Table 2: Cronbach's alpha at visit 1 and test-retest reliability (Intraclass Correlation Coefficient (ICC))for GSRS and QOLRAD domains 
between visits 1 and 2.
Domains Cronbach's alpha ICC
GSRS
Reflux 0.70 0.60
Abdominal pain 0.53 0.49
Indigestion 0.86 0.73
Diarrhoea 0.91 0.67
Constipation 0.75 0.72
QOLRAD
Emotional distress 0.94 0.84
Food/drink problems 0.91 0.76
Physical/social functioning 0.91 0.84
Sleep disturbance 0.92 0.75
Vitality 0.90 0.70Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/62
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reliability of 'Abdominal Pain' may suggest that pain can
be perceived differently from time to time and/or that
pain intensity may vary considerably even during a
shorter period of time. More research is needed to explore
this issue. All domains of QOLRAD had excellent internal
consistency and test-retest reliability.
The construct validity of GSRS and QOLRAD has also
been documented. The relevant domain scores of the
Physician-assessed overall severity and frequency of symptoms and the GSRS domain scores Figure 1
Physician-assessed overall severity and frequency of symptoms and the GSRS domain scores.
Table 3: Correlation coefficients (Pearson) between GSRS, QOLRAD and SF-36 domains, HAD and physician-assessed frequency and 
severity of symptoms.
Instruments GSRS 
Reflux
GSRS 
Abdominal 
Pain
GSRS 
Indigestion
GSRS 
Diarrhoea
GSRS 
Constipation
QOLRAD 
Emotional 
Distress
QOLRAD 
Sleep 
Disturbance
QOLRAD 
Food/drink 
problems
QOLRAD 
Physical/ Social 
Functioning
QOLRA
D Vitality
SF-36 Bodily pain -0.36 -0.51 -0.37 -0.19 -0.22 0.48 0.49 0.50 0.49 0.49
SF-36 General Health -0.09 -0.34 -0.20 -0.24 -0.26 0.39 0.45 0.37 0.47 0.44
SF-36 Mental Heath -0.17 -0.36 -0.35 -0.25 -0.36 0.63 0.48 0.51 0.61 0.60
SF-36 Physical functioning -0.29 -0.34 -0.33 -0.19 -0.38 0.51 0.52 0.40 0.59 0.48
SF-36 Role – Emotional -0.21 -0.34 -0.33 -0.24 -0.40 0.52 0.36 0.39 0.47 0.52
SF-36 Role – Physical -0.24 -0.44 -0.36 -0.25 -0.44 0.50 0.43 0.48 0.58 0.54
SF-36 Social Functioning -0.30 -0.41 -0.29 -0.20 -0.38 0.70 0.55 0.54 0.71 0.64
SF-36 Vitality -0.38 -0.44 -0.30 -0.28 -0.37 0.60 0.53 0.59 0.65 0.69
SF-36 PCS* -0.30 -0.44 -0.32 -0.20 -0.33 0.43 0.52 0.44 0.56 0.46
SF-36 MCS** -0.22 -0.35 -0.31 -0.25 -0.37 0.63 0.44 0.49 0.58 0.61
QOLRAD Emotional 
Distress
-0.43 -0.45 -0.39 -0.19 -0.28
QOLRAD Food/drink 
problems
-0.53 -0.54 -0.44 -0.25 -0.34
QOLRAD Physical/social 
functioning
-0.43 -0.44 -0.40 -0.23 -0.36
QOLRAD Sleep disturbance -0.51 -0.48 -0.41 -0.34 -0.30
QOLRAD Vitality -0.54 -0.53 -0.46 -0.35 -0.31
HAD Anxiety score 0.13 0.36 0.36 0.32 0.34 -0.51 -0.37 -0.44 -0.48 -0.49
HAD Depression score 0.09 0.26 0.27 0.32 0.30 -0.48 -0.39 -0.38 -0.53 -0.48
Physician-assessed 
symptoms
Frequency of heart burn 
symptoms
0.36 0.28 0.13 -0.07 0.05 -0.44 -0.32 -0.40 -0.36 -0.37
Severity of heart burn 
symptoms
0.23 0.13 0.08 -0.15 0.29 -0.28 -0.20 -0.24 -0.30 -0.28
* Physical Component Summary score ** Mental Component Summary score Notes: Bolded coefficients are significant p < 0.0003
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GSRS and QOLRAD significantly correlated. The GSRS
domains of Abdominal Pain and Indigestion significantly
(negatively) correlated with most of the domains of the
SF-36. All QOLRAD domains correlated significantly with
the domains of SF-36, thereby confirming the construct
validity of QOLRAD. Known-groups validity was also
proven; GSRS and QOLRAD did differentiate between
patients with different frequency and severity of symp-
toms, which is comparable to previous findings [12,36].
The moderate or low correlation between patient-
reported and physician-assessed symptom frequency and
severity indicates that symptom assessment should be bal-
anced between clinician examination and patient report
[12,37].
In conclusion, the German translations of GSRS and
QOLRAD are reliable and valid.
Authors' contributions
IW conceived the study and KRK managed its design and
coordination. JC was responsible for the statistical analy-
sis. IW co-participated in the overall process.
PM, AM, JL, EB, SM, were the best recruiters of patients in
the study and made comments to the draft manuscript. All
authors read and approved the final manuscript.
Acknowledgement
We owe special thanks to Uwe Schöning and Werner Marquardt, Astra-
Zeneca Germany, for their support and assistance in this study.
This study was funded by AstraZeneca R&D, Mölndal, Sweden.
References
1. Velanovich V, Vallance SR, Gusz JR, Tapia FV and Harkabus MA:
Quality of life scale for gastroesophageal reflux disease. J Am
Coll Surg 1996, 183:217-224.
2. Wiklund I: Quality of life in patients with gastroesophageal
reflux disease. American Journal of Gastroenterology 2001, 96:S46-53.
3. Moyer CA and Fendrick AM: Measuring health-related quality of
life in patients with upper gastrointestinal disease. Dig Dis
1998, 16:315-324.
4. Talley NJ, Fullerton S, Junghard O and Wiklund I: Quality of life in
patients with endoscopy-negative heartburn: reliability and
sensitivity of disease-specific instruments. Am J Gastroenterol
2001, 96:1998-2004.
5. Symonds T, Berzon R, Marquis P, Rummans TA, Aaronson N, Barof-
sky I, Bonomi A, Bullinger M, Cappelleri JC, Cella D, Fairclough DL,
Ferrans CE, Frost MH, Guyatt GH, Hays RD, Moinpour CM, Moyni-
han T, Norman G, Osoba D, Patrick D, Revicki D, Scott C, Sloan JA,
Sprangers M, Varricchio C, Wong G, Wu A and Wyrwich K: The
clinical significance of quality-of-life results: Practical consid-
erations for specific audiences.  Mayo Clinic Proceedings 2002,
77:572-583.
6. Lohr K: Assessing health status and quality-of-life instru-
ments: attributes and review criteria. Quality of Life Research
2002, 11:193-205.
7. Leidy NK, Revicki DA and Genesté B: Recommendations for
evaluating the validity of quality of life claims for labeling and
promoting. Value in Health 1999, 2:113-127.
8. Chassany O, Sagnier P, Marquis P, Fullerton S and Aaronson N:
Patient-reported outcomes: The example of health-related
quality of life - A European guidance document for the
improved integration of health-related quality of life assess-
ment in the drug regulatory process. Drug Information Journal
2002, 36:209-238.
9. Guyatt GH, Feeny DH and Patrick DL: Measuring health-related
quality of life. Ann Intern Med 1993, 118:622-629.
10. Fitzpatrick R, Davey C, Buxton MJ and Jones DR: Evaluating
patient-based outcome measures for use in clinical trials.
Health Technology Assessment (Winchester, England) 1998, 2:i-74.
11. Svedlund J, Sjodin I and Dotevall G: GSRS--a clinical rating scale
for gastrointestinal symptoms in patients with irritable
bowel syndrome and peptic ulcer disease. Digestive Diseases &
Sciences 1988, 33:129-134.
12. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen
van Zanten S, Pare P, Chiba N, Leddin DS, Bigard MA, Colin R and
Physician-assessed overall severity and frequency of symptoms and the QOLRAD domain scores Figure 2
Physician-assessed overall severity and frequency of symptoms and the QOLRAD domain scores.
1
2
3
4
5
6
7
Emotional distress
Food/drink problems
Physical/social functioning
Sleep disturbance
Vitality
Mild 
Moderate
Severe
1
2
3
4
5
6
7
Emotional distress
Food/drink problems
Physical/social functioning
Sleep disturbance
Vitality
1-3 days
4-6 days
7 daysPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/62
Page 8 of 8
(page number not for citation purposes)
Schoenfeld P: Quality of Life in Reflux and Dyspepsia patients.
Psychometric documentation of a new disease-specific ques-
tionnaire (QOLRAD). Eur J Surg Suppl 1998, 583:41-49.
13. Ware J. E., Jr. and Sherbourne CD: The MOS 36-item short-form
health survey (SF-36). I. Conceptual framework and item
selection. Med Care 1992, 30:473-483.
14. Zigmond AS and Snaith RP: The hospital anxiety and depression
scale. Acta Psychiatr Scand 1983, 67:361-370.
15. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J and Wik-
lund I: Well-being and gastrointestinal symptoms among
patients referred to endoscopy owing to suspected duodenal
ulcer. Scand J Gastroenterol 1995, 30:1046-1052.
16. Dimenas E, Carlsson G, Glise H, Israelsson B and Wiklund I: Rele-
vance of norm values as part of the documentation of quality
of life instruments for use in upper gastrointestinal disease.
Scand J Gastroenterol Suppl 1996, 221:8-13.
17. Wiklund IK, Fullerton S, Junghard O and Talley NJ: Interpretability
and meaningfulness of quality of life changes in patients with
heartburn. Annual Meeting at Digestive Disease Week, the American
Gastroenterological Association (AGA) San Diego, California; 2000. 
18. Kulich KR, Wiklund I and Junghard O: Factor structure of the
quality of life in reflux and dyspepsia (QOLRAD) question-
naire evaluated in patients with heartburn predominant
reflux disease. Quality of Life Research 2003, 6:699-708.
19. Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P,
Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L and Sullivan M: The
factor structure of the SF-36 Health Survey in 10 countries:
results from the IQOLA Project. International Quality of
Life Assessment. J Clin Epidemiol 1998, 51:1159-1165.
20. Ware JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J,
Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M and Thunedborg
K: The equivalence of SF-36 summary health scores esti-
mated using standard and country-specific algorithms in 10
countries: results from the IQOLA Project. International
Quality of Life Assessment. J Clin Epidemiol 1998, 51:1167-1170.
21. Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R,
Robertson B and Bliss J: The factor structure and factor stability
of the hospital anxiety and depression scale in patients with
cancer. Br J Psychiatry 1991, 158:255-259.
22. Herrmann C: International experiences with the Hospital
Anxiety and Depression Scale-a review of validation data
and clinical results. J Psychosom Res 1997, 42:17-41.
23. Drummond HE, Ghosh S, Ferguson A, Brackenridge D and Tiplady B:
Electronic quality of life questionnaires: a comparison of
pen-based electronic questionnaires with conventional
paper in a gastrointestinal study. Qual Life Res 1995, 4:21-26.
24. Cronbach LJ: Coefficient alpha and the internal structure of
tests. Psychometrika 1951, 16:297-334.
25. Hinkle DE, Jurs SG and Wiersma W: Applied statistics for the
behavioral sciences. 2nd --th edition. Boston, Houghton Mifflin;
1988:xix, 682. 
26. Kerlinger Fred N. and Lee Howard B.: Foundations of behavioral
research. 4thth edition. Fort Worth, TX, Harcourt College Publishers;
2000:xxv, 890, [82]. 
27. Fayers Peter M. and Machin David: Quality of life: assessment,
analysis and interpretation. Chichester, Wiley; 2000:xii, 404. 
28. Ware J. E., Jr., Kosinski M, Bayliss MS, McHorney CA, Rogers WH and
Raczek A: Comparison of methods for the scoring and statis-
tical analysis of SF-36 health profile and summary measures:
summary of results from the Medical Outcomes Study. Med-
ical Care 1995, 33:AS264-79.
29. SAS Institute Inc 8.02. Cary, NC, USA; 2001. 
30. Curtin F and Schulz P: Multiple correlations and Bonferroni's
correction. Biological Psychiatry 1998, 44:775-777.
31. Halling K, Långström G and Wiklund I: Handling missing data in
quality of life questionnaires: Experience from clinical trials.
6th Annual Conference of the International Society for Quality of Life
Research, Barcelona, Spain; 1999. 
32. Hollenz M, Stolte M and Labenz J: Pravalenz der Refluxkrankheit
in einer Allgemeinpraxis.  Deutsche Medizinische Wochenschrift
2002, 127:1007-1012.
33. Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K,
Lundell L, Pedersen SA, Carlsson R, Junghard O, Stubberod A and
Anker-Hansen O: Quality of life in patients with heartburn but
without esophagitis: effects of treatment with omeprazole.
Am J Gastroenterol 1999, 94:1782-1789.
34. Crawley J, Frank L, Joshua-Gotlib S, Flynn J, Frank S and Wiklund I:
Measuring change in quality of life in response to Helico-
bacter pylori eradication in peptic ulcer disease: the
QOLRAD. Dig Dis Sci 2001, 46:571-580.
35. Wahlqvist P, Carlsson J, Stalhammar NO and Wiklund I: Validity of
a Work Productivity and Activity Impairment questionnaire
for patients with symptoms of gastro-esophageal reflux dis-
ease (WPAI-GERD)-results from a cross-sectional study.
Value in Health 2002, 5:106-113.
36. Glise H and Wiklund I: Health-related quality of life and gas-
trointestinal disease. Journal of Gastroenterology & Hepatology 2002,
17 Suppl:S72-84.
37. Slevin ML, Plant H, Lynch D, Drinkwater J and Gregory WM: Who
should measure quality of life, the doctor or the patient? Brit-
ish Journal of Cancer 1988, 57:109-112.